SBARRATO T
| : | - | |
|---|---|---|
| Membre du laboratoire | : | Non |
| Organisme | : | - |
| Equipes | : | - |
Références (1)
ACL
Ghezali L, Landri M, Monville F, Leca V, Vasse T, Hamdad C, Mercadal M, Vanhille L, Kassambara A, Sbarrato T, Le Ray M, Roumieux M, Malkoun R, Resseguier N, Boyer A, Audigier-Valette C, Martinez S, Pegliasco H, Ray P, Falchero L, Serre A, Cloarec N, Lebas L, Hominal S, Barré P, Zahi S, Frikha A, Bory P, Laborde L, Mazières J, Martin V, Mazières J, Pérol M, Greillier L, Barlesi F, Fieschi J (2022) Brightplex® TCE and brightplex® MDSC assays combination improves advanced NSCLC patients’ stratification under anti-PD1/L1 immunotherapy in the PIONeeR project. J immunotherap cancer 10 | doi: 10.1136/jitc-2022-SITC2022.0701